Using the Bayley-4 and Vineland-3 in Angelman syndrome: barriers, solutions, and challenging items
Abstract Objective The Bayley Scales of Infant and Toddler Development- 4th Edition (Bayley-4) and Vineland Adaptive Behavior Scales – 3rd Edition (Vineland-3) are outcome measures often considered as primary endpoints in clinical trials for Angelman syndrome (AS). We explored barriers encountered w...
Saved in:
| Main Authors: | Sean N. Halpin, Sarah Nelson Potter, Angela Gwaltney, Anjali Sadhwani, Katherine C. Okoniewski, Anne C. Wheeler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13023-025-03817-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute administration of lovastatin had no pronounced effect on motor abilities, motor coordination, gait nor simple cognition in a mouse model of Angelman syndrome
by: Timothy A. Fenton, et al.
Published: (2025-05-01) -
Myoclonus in Angelman Syndrome
by: J Gordon Millichap
Published: (1996-10-01) -
Epilepsy in Angelman’s Syndrome
by: J Gordon Millichap
Published: (2009-12-01) -
Neurologic and EEG Findings in Angelman Syndrome
by: J Gordon Millichap
Published: (2005-02-01) -
Exaggerated T‐wave alternans in children with Angelman syndrome
by: Eleonora Tamilia, et al.
Published: (2024-12-01)